ATE479769T1 - Glycoprotein sowie verfahren zu dessen herstellung - Google Patents

Glycoprotein sowie verfahren zu dessen herstellung

Info

Publication number
ATE479769T1
ATE479769T1 AT02736110T AT02736110T ATE479769T1 AT E479769 T1 ATE479769 T1 AT E479769T1 AT 02736110 T AT02736110 T AT 02736110T AT 02736110 T AT02736110 T AT 02736110T AT E479769 T1 ATE479769 T1 AT E479769T1
Authority
AT
Austria
Prior art keywords
mannose
phosphate
glycoproteins
reducing terminal
yeast
Prior art date
Application number
AT02736110T
Other languages
English (en)
Inventor
Yasunori Chiba
Yoshifumi Jigami
Hitoshi Sakuraba
Kazuo Kobayashi
Makoto Takeuchi
Original Assignee
Nat Inst Of Advanced Ind Scien
Tokyo Metropolitan Org Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Inst Of Advanced Ind Scien, Tokyo Metropolitan Org Med Res filed Critical Nat Inst Of Advanced Ind Scien
Application granted granted Critical
Publication of ATE479769T1 publication Critical patent/ATE479769T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
AT02736110T 2001-06-14 2002-06-14 Glycoprotein sowie verfahren zu dessen herstellung ATE479769T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001180907A JP4742191B2 (ja) 2001-06-14 2001-06-14 糖蛋白質およびその製造方法
PCT/JP2002/005965 WO2002103027A1 (fr) 2001-06-14 2002-06-14 Glycoprotéine et procédé de production

Publications (1)

Publication Number Publication Date
ATE479769T1 true ATE479769T1 (de) 2010-09-15

Family

ID=19021250

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02736110T ATE479769T1 (de) 2001-06-14 2002-06-14 Glycoprotein sowie verfahren zu dessen herstellung

Country Status (8)

Country Link
US (1) US7579166B2 (de)
EP (1) EP1408117B1 (de)
JP (1) JP4742191B2 (de)
KR (1) KR100888316B1 (de)
CN (1) CN1298862C (de)
AT (1) ATE479769T1 (de)
DE (1) DE60237520D1 (de)
WO (1) WO2002103027A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449308B2 (en) * 2000-06-28 2008-11-11 Glycofi, Inc. Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
JP4931332B2 (ja) * 2004-03-31 2012-05-16 株式会社日立ハイテクノロジーズ 糖の除去方法
CA2623197A1 (en) * 2005-09-22 2007-03-29 Prosci Incorporated Glycosylated polypeptides produced in yeast mutants and methods of use thereof
KR100757544B1 (ko) * 2005-11-08 2007-09-10 엘지전자 주식회사 플라즈마 디스플레이 패널의 화상처리 장치 및 화상처리방법
CA2626092A1 (en) 2005-11-18 2007-05-24 Tokyo Metropolitan Organization For Medical Research Novel highly functional enzyme having modified substrate-specificity
DK2508612T3 (en) 2007-04-03 2018-01-22 Oxyrane Uk Ltd Glycosylation of molecules
JP5507242B2 (ja) 2007-05-18 2014-05-28 公益財団法人東京都医学総合研究所 酵素補充療法用医薬組成物
CN102712914A (zh) * 2009-09-29 2012-10-03 根特大学 水解甘露糖-1-磷酸-6-甘露糖连接为磷酸-6-甘露糖
CA2781240A1 (en) 2009-11-19 2011-05-26 Oxyrane Uk Limited Yeast strains producing mammalian-like complex n-glycans
EA022220B1 (ru) * 2010-02-24 2015-11-30 Сюменекс А/С Способ получения и очистки рекомбинантной лизосомальной альфа-маннозидазы
CA2812872C (en) 2010-09-29 2021-08-03 Oxyrane Uk Limited De-mannosylation of phosphorylated n-glycans
CN103328646B (zh) * 2010-09-29 2021-06-18 奥克西雷恩英国有限公司 能够使甘露糖-1-磷酸-6-甘露糖连接脱帽并使磷酸化的n-聚糖脱甘露糖基化的甘露糖苷酶及促进糖蛋白的哺乳动物细胞摄取的方法
EP2633065A4 (de) * 2010-10-29 2014-05-07 Shire Human Genetic Therapies Assays und kits zur bestimmung einer galactocerebrosidasewirkung auf einem festen träger
EP2699676A1 (de) * 2011-04-22 2014-02-26 Genzyme Corporation Modifizierte saure alpha-glukosidase mit beschleunigter verarbeitung
WO2012147933A1 (ja) * 2011-04-28 2012-11-01 国立大学法人大阪大学 リソソーム病治療用医薬組成物
US20140219988A1 (en) * 2011-05-19 2014-08-07 Tokyo Metropolitan Institute Of Medical Science Rrecombinant human saposin b protein containing phosphorylated glucose ring and use thereof
CN104379162B (zh) 2012-03-15 2017-03-15 奥克西雷恩英国有限公司 用于治疗蓬佩氏病的方法和材料
CA2888628A1 (en) 2012-10-19 2014-04-24 Tokushima University Novel high functional enzyme having modified substrate specificity of human beta-hexosaminidase b and exhibiting protease resistance
JP6169552B2 (ja) * 2013-10-01 2017-07-26 Ｊｃｒファーマ株式会社 ２−アミノピリジンによる糖鎖の標識法
KR101750888B1 (ko) 2014-09-23 2017-06-26 한국생명공학연구원 YlMpo1 과발현을 이용한 만노스인산화 증대 방법
GB201508025D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Fabry disease gene therapy
WO2016195394A1 (ko) * 2015-06-02 2016-12-08 한국생명공학연구원 효모 세포벽 만노단백질 유래의 당사슬을 이용한 만노스-6-인산 당사슬이 부가된 당단백질의 제조방법
WO2017170896A1 (ja) 2016-03-30 2017-10-05 国立大学法人徳島大学 マンノース－６－リン酸基含有糖蛋白質の製造方法、及び蛍光基結合型マンノース－６－リン酸基含有糖蛋白質の細胞内分布を検出する方法
CN108795871B (zh) * 2017-04-28 2021-12-03 江南大学 用于生产糖蛋白的动物细胞株及方法、糖蛋白及其用途
JP7134444B2 (ja) 2018-01-26 2022-09-12 国立大学法人徳島大学 テイ－サックス病及びザンドホッフ病治療用の新規アデノ随伴ウイルスビリオン

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401650A (en) * 1990-10-24 1995-03-28 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-galactosidase A
JP3091851B2 (ja) * 1992-11-06 2000-09-25 工業技術院長 哺乳類の高マンノース型糖蛋白質糖鎖の酵母による製造法
JP2767401B2 (ja) * 1995-11-17 1998-06-18 工業技術院長 酵母のマンノース−１−リン酸転移酵素遺伝子およびこれを利用するマンノース−１−リン酸含有酸性糖鎖の製造方法
JP2826636B2 (ja) * 1997-10-30 1998-11-18 工業技術院長 酵母のマンノース−１−リン酸転移酵素遺伝子を利用するリン酸含有酸性糖鎖の製造方法
WO2001014522A1 (fr) * 1999-08-19 2001-03-01 Kirin Beer Kabushiki Kaisha Nouvelles variantes de levure et procede de production de glycoproteine
US6642038B1 (en) 1999-09-14 2003-11-04 Genzyme Glycobiology Research Institute, Inc. GlcNAc phosphotransferase of the lysosomal targeting pathway

Also Published As

Publication number Publication date
CN1298862C (zh) 2007-02-07
JP4742191B2 (ja) 2011-08-10
KR20040026663A (ko) 2004-03-31
EP1408117A1 (de) 2004-04-14
EP1408117B1 (de) 2010-09-01
WO2002103027A1 (fr) 2002-12-27
DE60237520D1 (de) 2010-10-14
US20050064539A1 (en) 2005-03-24
CN1541275A (zh) 2004-10-27
JP2002369692A (ja) 2002-12-24
EP1408117A4 (de) 2005-01-26
US7579166B2 (en) 2009-08-25
KR100888316B1 (ko) 2009-03-11

Similar Documents

Publication Publication Date Title
DE60237520D1 (de) Glycoprotein sowie verfahren zu dessen herstellung
DE59410052D1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
ATE221086T1 (de) Photovernetztes hyaluronsäuregel und verfahren zu dessen herstellung
ATE315050T2 (de) Verfahren zur herstellung von mehrfach vernetzten hyaluronsäurederivaten
MXPA04010311A (es) Composicion farmaceutica.
EP1095656A3 (de) Pharmazeutische Zubereitung mit dem Cholinesterase-Hemmstoff Galanthamin
GEP20012414B (en) Semicarbazones Having CNS Activity and Pharmaceutical Preparations Containing the Same
BR9807936A (pt) Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação
ATE541583T1 (de) Enzym-enthaltendes präparat, verfahren zur herstellung und verwendung
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE115554T1 (de) Cyclopropenonderivate.
ATE181507T1 (de) Harpagosid-angereicherter extrakt aus harpagophytum procumbens und verfahren zu seiner herstellung
WO1997023507A3 (en) New form of amphiregulin, methods for producing and using the same and compositions comprising the same
DE50301507D1 (de) 17a-FLUORALKYL-11BETA-BENZALDOXIM-STEROIDE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE STEROIDE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN
ATE191456T1 (de) Monofunktionalisierte edta-, dtpa- und ttha- derivate und deren verwendung zur herstellung von mitteln für die medizinische diagnostik oder therapie
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
ATE309981T1 (de) Gallensäure-substituierte phenyl- alkenoylguanidine, verfahren zu ihrer herstellung,ihre verwendung als medikamente oder diagnostika sowie sie enthaltende medikamente
DE50301697D1 (de) Verfahren zur herstellung von polyetheralkoholen
WO1998011919A3 (en) Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof
ATE341630T1 (de) Verwendung von pankreatischer procarboxypeptidase b zur herstellung von insulin
ATE304527T1 (de) Bis-basische verbindungen als tryptase- inhibitoren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
AU2001270613A1 (en) Method for the production of faithfully-reproduced medical implants and epiprostheses and said implants and epiprostheses
DE59507710D1 (de) Dipeptid-derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
ATE394408T1 (de) Ustilipide, verfahren zu deren herstellung sowie deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties